Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special PopulationsRelease Date:Research Inflammation & Immunology China Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) PathogensRelease Date:Research Inflammation & Immunology China Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy CareRelease Date:Partner: The Japanese Society for Cutaneous Immunology and AllergyQuality Improvement Inflammation & Immunology Japan Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in ChinaRelease Date:Research Inflammation & Immunology China Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Title Grant Type Focus Area Country Application Due Date An Accord for a Healthier World: Digital Health Tools to Improve Multidisciplinary Patient CareRelease Date:Quality Improvement Support for the Professions Senegal PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology China Improving cancer care in patients with metastatic breast cancerRelease Date:Quality Improvement Oncology Kazakhstan An Accord for a Healthier World: Preceptorships for Rheumatology (African French Speaking Countries Geographic Scope)Release Date:Education Inflammation & Immunology All Improving Health Equity in IBD through Disparities ResearchRelease Date:Research Inflammation & Immunology All Emerging Science in the Management of Acute Myeloid LeukemiaRelease Date:Education Oncology All Addressing Systemic Drivers of Racial Health InequitiesRelease Date:Quality Improvement Health Equity USA Diversity in Postmarketing Drug Safety SurveillanceRelease Date:Research Patient Safety USA Addressing Barriers to Care: Destigmatizing Breast Cancer through Patient EducationRelease Date:Education Oncology Ghana, Rwanda Increasing Awareness and Understanding of Duchenne Muscular Dystrophy in Latin America, Africa, Middle East and Asia-PacificRelease Date:Education Rare Disease All Improving Education Disparities of Young Gatroenterologists to Deliver Appropriate Medical Care to IBD PatientsRelease Date:Education Inflammation & Immunology Argentina, Brazil, India, Malaysia, Mexico, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates 2023 Inflammatory Bowel Disease (IBD) Fellowship – IndiaRelease Date:Fellowship Inflammation & Immunology India